ÎPERATIVE TREATMENT OF PREMALIGNANT AND MALIGNANT CHANGES ON CERVIX UTERI AT GYNECOLOGY & OBSTETRICS CLINIC OF CLINICAL CENTER OF MONTENEGRO IN THE PERIOD OF 1999-2008

A. Boljević ,
A. Boljević

Health Care Center of Podgorica , Podgorica , Montenegro

G. Globarević-Vukčević ,
G. Globarević-Vukčević

Obstetric s& Gynecology Clinic of Clinical Center of Montenegro Montenegro

S. Raičević ,
S. Raičević

Obstetric s& Gynecology Clinic of Clinical Center of Montenegro Montenegro

M. Jovanović ,
M. Jovanović

Health Care Center of Podgorica , Podgorica , Montenegro

D. Kljakić
D. Kljakić

General Hospital of Bar Montenegro

Published: 01.12.2009.

Volume 37, Issue 2 (2009)

pp. 109-113;

https://doi.org/10.70949/pramed200902306B

Abstract

Cervix cancer is the second most frequently found cancer in women, after breast cancer and represent one of the biggest problems of modern medicine. The aim of treatment is to determine the frequency of certain premalignant and malignant changes in cervix and the method of its operative treatment. By a retrospective method, 360 women have been operated due to the changes in cervix from 1999-2008 at Obstetrics &Gynecology Clinic of Clinical Center of Montenegro. Out of this number the total of 297 women with premalignant lesions of cervix was found and 63 women at an operable stage of cancer. With premalignant cervix changes the most frequent indication for operation was CIN III - 24.57% of patients. Cervix conization -80.13% is most frequently used as an operable intervention with premalignant changes in cervix. The groups of 40-49 years of age and 50-59 years of age are the ages of patients with most frequently conization done. The most frequent indication to operate malignant cervix was Ca I b. Wertheim-Meigs radical hysterectomy was performed with all patients with operable malignant changes. With an early identification, an adequate evaluation, the treatment, constant and cautious monitoring, almost any cervical intraepithelial neoplasia can be cured. Without the treatment, 30-50% of cervical dysplasia can advance into and invasive cervix cancer. 

Keywords

References

1.
Koss LG. Statement of caution in the interpretation of papillomavirus-associated lesions of the epithelium of uterine cervix. Am J Obstet Gynecol. 146(125).
2.
Reid R. Genital warts and cervical cancer. A colposcopic index for differentiating subclinical papillomaviral infection from cervical intraepithelial neoplasia. Am J Obstet Gynecol.
3.
Platz-Christensen JJ, Sundstrom E, Larsson PG. Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand. 73(7):586–8.
4.
Ginekologija PS. Elit Medica. :153–65.
5.
Parkin DM, Whelan SL. Cancer Incidence in Five Continents. Vol. VIII.
6.
Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 12(2):186–92.
7.
Nunez-Troconis JT. Cervical intraepithelial neoplasia: Chlamydia trachomatis and other cofactors. Invest Clin. 36(3):101–16.
8.
Neuer A, Menton M. Bacteriological findings in patients with cervical intra-epithelial neoplasia. Zentralbl Gynakol. 117(8):435–8.
9.
Mikamo H, Izumi K, Ito K. Internal bacterial flora of solid uterine cervical cancer. Kansenshogaku Zasshi. 67(11):1057–61.
10.
Collaborators MWS. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet. 361:419–27.
11.
Micheli A, Coebergh JW. European health systems and cancer care. Ann Oncol. 14.
12.
Luesley DM, McCrum A, Teng PB. Complications of cone biopsy related to the dimensions of the cone and the influence of the prior assessment. Br J Obstet Gynaecol. 91:158–64.
13.
Kurjak A. Tumori vrata maternice. Ginekologija i perinatologija.
14.
Abdul-Karim FW, Nunez C. Cervical intraepithelial neoplasia after conization: A study of 522 consecutive cervical cones. Obstet Gynecol. 65:77–81.
15.
Scott G, R.S. Danforth’s Obstetrics and Gynecology.
16.
Ito K, Tamaya T, Watanabe K. Intravaginal bacterial flora in patients with uterine cervical cancer with special reference to Gardnerella vaginalis. Nippon Sanka Fujinka Gakkai Zasshi. 42(11):1551–5.
17.
Ferlay J, Globocan BF. Cancer incidence, Mortality and Prevalence Worldwide.
18.
Heinrich I, Heinrich J. Chlamydia infection and CIN. Zentralbl Gynakol. 116(7):410–5.
19.
Harnekar AB, Leiman G, Markowitz S. Cytologically detected chlamydial changes and progression of cervical intraepithelial neoplasias. Acta Cytol. 19(5):661–4.
20.
Frega A, Stentella P, Spera G. Cervical intraepithelial neoplasia and bacterial vaginosis: correlation or risk factor. Eur J Gynecol Oncol. 18(1):76–7.
21.
Guijon F, Paraskevas M, Rand F. Vaginal microbial flora as a cofactor in the pathogenesis of the uterine cervical intraepithelial neoplasia. Ind Gynecol Obstet. 37(3):185–91.
22.
Guaschino S, Stola E, Spinillo A. Chlamydia trachomatis and cervical intraepithelial neoplasia. Clin Exp Obstet Gynecol. 15(3):98–101.
23.
Gonzalez-Falco J, Jurado M, Madamba AM. Gardnerella vaginalis and mosaic colposcopic pattern of the cervix: casual or casual association. Gynecol Obstet Invest. 21(2):108–10.
24.
Dietl J, Semm K, Hedderich J. CIN and preclinical cervical carcinoma. A study of morbidity trends over a 10-year period. Int J Gynecol Obstet. 21:283–9.
25.
Alberico S, Facca MC, Bonito L. Frequency of cervico-vaginal infections (Trichomonas vaginalis; Chlamydia trachomatis; herpes simplex virus; human papilloma virus) in cervical intraepithelial neoplasia. Eur J Gynecol Oncol. 9(3):252–7.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by